# SEG Owner Review Closure Assessment Report

**Document ID:** `SEG_OWNER_REVIEW_CLOSURE_ASSESSMENT_REPORT`  
**Mode:** `CONTROLLED MEDICAL GOVERNANCE EXECUTION`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Owner authority:** Dr. Alaa Al-Asfar — SEG Medical Content Owner; Emergency Medicine Physician; Project Lead  
**Assessment timestamp:** `2026-08-22T15:02:03+00:00` — observed closure-assessment timestamp

## 1. Executive determination

This closure assessment evaluated only the evidence presently supported for Drug HTML, OSCE Atlas, and PreTest. The assessment recorded source-specific findings, limitations, missing requirements, and owner-governed review outcomes against the locked artifact references. It did not invent clinical conclusions, correct source material, or treat artifact structure as clinical validation.

All three sources remain in the allowed decision state:

```text
Drug HTML   = OWNER_REVIEW_BLOCKED
OSCE Atlas  = OWNER_REVIEW_BLOCKED
PreTest     = OWNER_REVIEW_BLOCKED
```

The owner-governed pathway is available for internally owned assets, and no mandatory external approval dependency is assumed solely because the artifacts are internal. However, source-specific review evidence, rights/provenance evidence, version closure, audit linkage, and explicit source-level approval remain separate requirements.[1]

## 2. Source decision summary

| Source | Reviewed scope | Evidence-supported positive findings | Main limitations/missing requirements | Final owner decision |
|---|---|---|---|---|
| Drug HTML | Emergency Medicine relevance; drug-information structure; safety metadata availability; metadata requirements | Exact retained HTML artifact and SHA-256 are recorded; structural observations include 19 `summaryData`, 21 `quick`, 47 `drugList`, and 20 `trapsList` entries | Clinical relevance, drug safety, dose/interaction/contraindication completeness, canonical source/version, provenance, rights, metadata closure, and dated clinical/drug-safety review are unresolved | `OWNER_REVIEW_BLOCKED` |
| OSCE Atlas | Clinical educational suitability; image organization and relevance; clinical labeling; accessibility requirements | Recovered package and hashes are recorded; 14 PNG members, station text, validation notes, and per-member integrity evidence are available; limited readability notes exist for two images | No completed educational-suitability, clinical-labeling, full 14-image visual, alt-text/equivalent-access, assistive-technology, canonical-source, lineage, rights, or dated review evidence | `OWNER_REVIEW_BLOCKED` |
| PreTest | Question structure; assessment usability; OCR impact; answer/explanation availability; metadata requirements | `UPD811-007` retained representation and SHA-256 are recorded; OCR/extraction corruption is explicitly documented without correction | Authoritative PDF/equivalent, question inventory, completeness/numbering baseline, answer-key and explanation inventory, OCR comparison, source/version, rights, provenance, and dated medical/assessment review are unresolved | `OWNER_REVIEW_BLOCKED` |

These decisions are review-closure assessments, not source approvals, source rejections, or normalization-readiness decisions.

## 3. Drug HTML closure assessment

### 3.1 Reviewed evidence and supported findings

The exact retained artifact is `LOCAL_INTAKE_ARTIFACT` at `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html`, with 25,918 bytes, 394 lines, and SHA-256 `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac`. Available read-only structure evidence records 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, and 20 `trapsList` entries. No explicit pairwise interaction table was observed in the available artifact evidence.[2]

These are structural observations only. They do not establish that the drug information is clinically relevant, complete, current, safe, correctly dosed, or suitable for emergency-medicine education. The absence of an observed interaction table is not evidence that interactions are absent.

### 3.2 Limitations and missing requirements

The canonical source identity, version/edition/date, original locator, source-to-HTML extraction history, complete provenance, rights for incorporated material, track/taxonomy evidence, metadata validation, and dated clinical or Pharmacology/Drug Safety review remain unresolved. The review record also lacks a separate completed technical/lineage review and an attributable clinical-review date.

### 3.3 Decision and next action

**Final owner decision:** `OWNER_REVIEW_BLOCKED`.

The next allowed action is to obtain or document the required source/version, provenance, rights, and metadata evidence, then record attributable owner-executed or owner-appointed Emergency Medicine and Pharmacology/Drug Safety reviews against the unchanged HTML hash. Each review must preserve exact locators, findings, conflicts, limitations, disposition, and audit linkage. No medication fact, dose, interaction, contraindication, or safety conclusion may be added through this report.

## 4. OSCE Atlas closure assessment

### 4.1 Reviewed evidence and supported findings

The locked target is `ATLAS_ASSET_OSCE_VISUAL_001`. The recovered package has inner SHA-256 `ca5a7f5713bf5101daa839a546633366d7b5b876604bd3dbf7cea2972d59f66e` and outer recovery-container SHA-256 `8182d243fc762e29efba5adeda4233042f5e337846b3fbe819fcd374ef948758`. The package contains 14 PNG members, station text, and validation notes. Per-member inventory and integrity evidence are available. Limited readability notes cover `016_first_degree_heart_block.png` and `142_acute_cholecystitis.png` only.[3]

The package inventory and two limited readability notes establish retained-artifact observations only. They do not establish clinical educational suitability, image relevance, labeling accuracy, visual quality for the other 12 images, accessibility, or learner-facing safety.

### 4.2 Limitations and missing requirements

The authoritative atlas/source identity, version/date, original locator, source-to-image and source-to-text lineage, per-image rights, complete educational-suitability finding, full clinical-label review, full 14-image visual review, alt-text/equivalent access, responsive legibility, contrast, non-color dependence, assistive-technology behavior, technical review, and dated attributable review records remain unresolved.

The recovered source claim referring to `CopyofEmergency-Medicine-FULL.pdf` is an artifact-level claim only. It does not establish authoritative source identity or rights. The PNG set must remain separate from the Clinical Images source family.

### 4.3 Decision and next action

**Final owner decision:** `OWNER_REVIEW_BLOCKED`.

The next allowed action is to obtain authoritative source/owner/version and rights/provenance evidence, reconcile the source-to-member lineage for all 14 PNGs, and record attributable owner-executed or owner-appointed Emergency Medicine/OSCE, Visual, and Accessibility reviews. Every image must receive an explicit disposition tied to its member hash. No image, caption, label, alt-text, or station text may be modified through this report.

## 5. PreTest closure assessment

### 5.1 Reviewed evidence and supported findings

The locked representation is `UPD811-007`, `pretestnew_Study_Guide_UTF8.txt`, with 131,490 bytes, 1,349 logical lines, and SHA-256 `b4ba84879b1247b9aaeb6172c6dffcb7dcc0860f8894e4651b2bc8a9fd669166`. The retained representation is hash-consistent, while known OCR/extraction corruption remains documented. No correction was attempted.[4]

The current evidence does not establish question structure completeness, assessment usability, answer-key availability, explanation availability, numbering integrity, or fidelity to an authoritative source. The absence of an answer-key or explanation inventory is an evidence gap, not a finding that the retained representation lacks answers or explanations.

### 5.2 Limitations and missing requirements

The authoritative `pretestnew.pdf` or independently verifiable equivalent, canonical identity/version/date/locator, immutable source-to-text comparison, OCR reconciliation, completeness and numbering baseline, answer-key inventory, explanation/rationale inventory, provenance, rights, track/taxonomy, and dated medical/assessment-quality review remain unresolved.

The retained OCR representation must remain unchanged until a read-only comparison and separately documented lineage decision are completed. No question, answer, explanation, numbering, or clinical claim may be invented or silently repaired.

### 5.3 Decision and next action

**Final owner decision:** `OWNER_REVIEW_BLOCKED`.

The next allowed action is to obtain or recover the authoritative representation, preserve the current text unchanged, perform the read-only source-to-text comparison and OCR discrepancy classification, and then record attributable owner-executed or owner-appointed Emergency Medicine and Assessment Quality reviews. Findings must use exact question/section locators and include disposition, limitations, and audit linkage.

## 6. Audit outcome events

The audit trail records the following append-only outcome events for this assessment:

| Event ID | Event type | Scope | Decision | Evidence basis | Limitations |
|---|---|---|---|---|---|
| `P0-AUD-012` | `OWNER_REVIEW_ASSESSMENT_COMPLETED` | Drug HTML | `OWNER_REVIEW_BLOCKED` | Locked HTML artifact and structural observations | Canonical source/version, provenance, rights, metadata, and clinical/drug-safety review evidence incomplete |
| `P0-AUD-013` | `OWNER_REVIEW_ASSESSMENT_COMPLETED` | OSCE Atlas | `OWNER_REVIEW_BLOCKED` | Locked package, 14-PNG inventory, hashes, and limited two-image readability notes | Canonical source/version, lineage, rights, full medical/visual/accessibility review, and educational-suitability evidence incomplete |
| `P0-AUD-014` | `OWNER_REVIEW_ASSESSMENT_COMPLETED` | PreTest | `OWNER_REVIEW_BLOCKED` | Locked `UPD811-007` representation, hash, and documented OCR issue | Authoritative source, OCR comparison, completeness, answer/explanation evidence, rights/provenance, and medical/assessment-quality review incomplete |

The event timestamp is the observed closure-assessment timestamp `2026-08-22T15:02:03+00:00`. It is not asserted as the clinical review date for any source. No clinical conclusion, approval, rights clearance, or normalization decision was created by these events.[5]

## 7. Remaining blockers

| Blocker | Drug HTML | OSCE Atlas | PreTest |
|---|---|---|---|
| Canonical source identity/version/locator | Open | Open | Open |
| Internal ownership scope | Declared | Declared | Declared |
| External/third-party rights | Open where applicable | Open for image/text material | Open for source-derived material |
| Provenance and lineage | Incomplete | Incomplete, including per-member lineage | Incomplete, including source-to-text/OCR lineage |
| Required owner-governed review | Not completed or dated | Not completed or dated | Not completed or dated |
| Source-specific quality review | Drug safety, metadata, technical | Full clinical-label, visual, accessibility, educational suitability | Assessment, OCR, metadata |
| Audit decision linkage | Outcome event recorded; approval event absent | Outcome event recorded; approval event absent | Outcome event recorded; approval event absent |

A review-assessment event is not a source-level approval event. All missing or unresolved requirements remain blocking under the fail-closed governance model.

## 8. Required next actions

The next allowed phase is evidence closure and completion of the owner-governed review domains against the exact immutable artifacts. The review records must receive actual review dates, attributable reviewer or owner-executed authority, qualification/role evidence, conflict declarations, exact locations, findings, limitations, dispositions, and append-only audit linkage.

After the applicable review streams are complete, rights/provenance, version, track/taxonomy, technical, visual, accessibility, OCR, and audit gates must be reassessed. A successful owner-governed review remains distinct from source approval. No source may be set to `READY_FOR_NORMALIZATION`, and no normalization, import, activation, publication, database change, schema change, or application change is permitted from this assessment.

## 9. Governance controls and non-actions

```text
INTERNAL_REVIEW_MODEL = OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
```

| Action | Result |
|---|---|
| Automatic source approval | `NO` |
| `READY_FOR_NORMALIZATION` set | `NO` |
| Clinical correctness or drug safety certified | `NO` |
| Rights cleared | `NO` |
| Content normalized or imported | `NO` |
| Content Records created | `NO` |
| Zod/Prisma/SQL/schema created | `NO` |
| Database/application changed | `NO` |
| Activation/publication performed | `NO` |
| Source artifact modified or OCR corrected | `NO` |

## 10. Final status

`SEG_OWNER_REVIEW_CLOSURE_ASSESSMENT_COMPLETE`

This status confirms completion of the available owner-governed review closure assessment and the recording of its outcome events. It does not certify clinical correctness, complete any source review, grant rights, approve a source, authorize normalization, or authorize import, activation, publication, database, schema, or application changes.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[2]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_OWNER_REVIEW_RECORD.md "SEG Drug HTML Owner Review Record"

[3]: file:///home/ubuntu/seg-internship-output/SEG_OSCE_ATLAS_OWNER_REVIEW_RECORD.md "SEG OSCE Atlas Owner Review Record"

[4]: file:///home/ubuntu/seg-internship-output/SEG_PRETEST_OWNER_REVIEW_RECORD.md "SEG PreTest Owner Review Record"

[5]: file:///home/ubuntu/seg-internship-output/SEG_P0_AUDIT_TRAIL_REGISTER.md "SEG P0 Audit Trail Register"

**Document status:** `OWNER_REVIEW_CLOSURE_ASSESSMENT_RECORDED_ALL_P0_BLOCKED`
